Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|September 8, 2010
A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentinHoward N Bockbrader, David Wesche, Raymond Miller, et al.
Neurology and Therapy|January 18, 2022
Development of a Population Pharmacokinetic Model for the Diroximel Fumarate Metabolites Monomethyl Fumarate and 2-Hydroxyethyl Succinimide Following Oral Administration of Diroximel Fumarate in Healthy Participants and Patients with Multiple SclerosisMita Kuchimanchi, Howard Bockbrader, Nancy Dolphin, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Population Pharmacokinetics Analysis To Inform Efavirenz Dosing Recommendations in Pediatric HIV Patients Aged 3 Months to 3 YearsMan Luo, Sunny Chapel, Heather Sevinsky, et al.
Journal of Clinical Pharmacology|January 18, 2008
Performance characteristics for some typical QT study designs under the ICH E-14 guidanceMatthew M Hutmacher, Sunny Chapel, Marilyn A Agin, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or shamRyan L Crass, Komal Prem, Francois Gaudreault, et al.
Journal of Clinical Pharmacology|August 12, 2025
Population Pharmacokinetic and Exposure-Efficacy Analyses of Valbenazine in Patients with Huntington's Disease: Supporting Dose Selection for Chorea ManagementHoa Q Nguyen, Ryan L Crass, Sunny Chapel, et al.
Clinical and Translational Science|March 2, 2021
Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson's diseaseFelix Agbo, Ryan L Crass, Yu-Yuan Chiu, et al.
Journal of Clinical Pharmacology|March 14, 2022
A Time-to-Event Exposure-Response Model for Amyloid-Related Imaging Abnormalities Following Administration of Aducanumab to Subjects With Early Alzheimer DiseaseKumar Kandadi Muralidharan, Sravan Karumanchi, Kenneth G Kowalski, et al.
Clinical Pharmacokinetics|March 15, 2005
Pharmacodynamic analysis of the microbiological efficacy of telithromycin in patients with community-acquired pneumoniaJun Shi, Marc Pfister, Stephen G Jenkins, et al.
Ophthalmology Science|January 24, 2025
Population Pharmacokinetics of Pegcetacoplan in Patients with Geographic Atrophy or Neovascular Age-related Macular DegenerationRyan L Crass, Komal Prem, Francois Gauderault, et al.
Pageof 3